Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)
China · Delayed Price · Currency is CNY 26.54
-0.16 (-0.60%)
At close: Jul 15, 2025, 2:57 PM CST
Shanghai Rightongene Biotechnology Company Description
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases.
It provides self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma.
The company was founded in 2012 and is based in Shanghai, China.
Shanghai Rightongene Biotechnology Co., Ltd.
| Country | China |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 401 |
| CEO | Hui Xiong |
Contact Details
Address: No. 147, Lane 1817 Shanghai, 201403 China | |
| Phone | 86 21 3328 2601 |
| Website | rightongene.com |
Stock Details
| Ticker Symbol | 688217 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Hui Xiong | Chairman and GM |
| Yan Li | Chief Financial Officer, Secretary of the Board of Directors and Accounting Supervisor |
| Jun Xiong | Deputy GM and Director |
| Chengli Zhang | Deputy General Manager |
| Liqun Xie | Deputy General Manager |
| Junyan He | Deputy General Manager |
| Yuwei Xue | Deputy General Manager |